Clinical Trial Update: Study to Evaluate Safety, Pharmacokinetics, and Antiviral Activity of Lenacapavir Administered Subcutaneously in Human Immunodeficiency Virus (HIV) -1 Infected Adults [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, pharmacokinetics, and antiviral activity of lenacapavir given subcutaneously in HIV-1 infected adults has completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Lenacapavir (lenacapavir)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV-1 Infection | Phase 1 | Status: COMPLETED | Results posted: 2020-12-09